SAM
CLB icon

Solaris Asset Management’s Core Laboratories CLB Stock Holding History

Solaris Asset Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-305
Closed -$33K – 73
2017
Q4 		$33K Hold
305
– – 0.02% 184
2017
Q3 		$30K Hold
305
– – 0.02% 199
2017
Q2 		$31K Hold
305
– – 0.02% 204
2017
Q1 		$35K Hold
305
– – 0.02% 186
2016
Q4 		$37K Hold
305
– – 0.02% 182
2016
Q3 		$34K Buy
+305
New +$35.1K 0.02% 193
2013
Q4 		– Sell
-60
Closed -$10K – 234
2013
Q3 		$10K Buy
+60
New +$9.31K 0.01% 213

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Solaris Asset Management's CLB Position: Q1 2018 in Review

Solaris Asset Management sold out of Core Laboratories (CLB) in Q1 2018, closing a stake of 305 shares — an estimated $33K sold.

Solaris Asset Management first reported a position in CLB in Q3 2013 and held it in 7 quarters. The position peaked at $37K in Q4 2016. 355 funds tracked by Wall St. Rank hold CLB as of Q1 2018.

  • Solaris Asset Management reported no remaining Core Laboratories position as of Q1 2018 after selling out during the quarter.
  • Solaris Asset Management sold 305 Core Laboratories shares in Q1 2018, an estimated $33K.
  • Solaris Asset Management first reported a position in Core Laboratories in Q3 2013 and held it in 7 quarters.
  • Solaris Asset Management's Core Laboratories position peaked at $37K in Q4 2016.
  • 355 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2018.

Based on Solaris Asset Management's 13F filing for Q1 2018, filed 16 Apr 2018.